1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Replication Protein A: new trials by email Literature Review of Replication Protein A trials Research Report on Replication Protein A
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109 GC1109 or Placebo of GC1109 - Anthrax | Phase 2 | Completed | Green Cross Corporation | 240 | 2021-07-14 | 2023-01-04 |
| UMD rPA Regimen Trial in Adults Anthrax vaccine absorbed made from Bacillus anthracis (AVA), Recombinant protein antigen (rPA) made from Bacillus anthrax, Recombinant protein antigen (rPA) made from Escherichia coli - Bacillus Anthracis (Anthrax) | Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 270 | 2010-08-27 |
Anthrax (2)
Green Cross Corporation (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
South Korea (1) · United States (1)
Eun Jung Lee, M.D. (1) · Jacob Lee, M.D. (1) · Nam Joong Kim, M.D. (1) · Seong Heon Wie, M.D. (1) · Won Suk Choi, M.D. (1)